| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |